Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity

Thyroid

Volumn 20, Issue 11, 2010, Pages 1307-1314

  Nishihara, Eijun ^a   Chen, Chun Rong ^b   Higashiyama, Takuya ^a   Mizutori Sasai, Yumiko ^a   Ito, Mitsuru ^a   Kubota, Sumihisa ^a   Amino, Nobuyuki ^a   Miyauchi, Akira ^a   Rapoport, Basil ^b  

^a KUMA HOSPITAL   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GENOMIC DNA; GLUTAMIC ACID; LYSINE; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; ASPIRATION BIOPSY; BIOASSAY; CASE REPORT; CLINICAL ASSESSMENT; CODON; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DNA SEQUENCE; ECHOGRAPHY; EXON; FAMILIAL DISEASE; FEMALE; FLOW CYTOMETRY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GOITER; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; JAPANESE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PEDIGREE ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SITE DIRECTED MUTAGENESIS; SUBCLINICAL HYPERTHYROIDISM; THYROID FUNCTION TEST; THYROID NODULE;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; FEMALE; HUMANS; HYPERTHYROIDISM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEDIGREE; POINT MUTATION; RECEPTORS, THYROTROPIN; THYROGLOBULIN; THYROID NODULE; THYROTROPIN;

EID: 78249258738     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0261     Document Type: Article

References (35)

1. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401.
2. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554.
3. Khoo DH, Parma J, Rajasoorya C, Ho SC, Vassart G 1999 A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. J Clin Endocrinol Metab 84:1459-1462. (Pubitemid 30644415)
4. Biebermann H, Schoneberg T, Krude H, Gudermann T, Gruters A 2000 Constitutively activating TSH-receptor mutations as a molecular cause of non-autoimmune hyperthyroidism in childhood. Langenbecks Arch Surg 385:390-392.
5. Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J, Ludgate M 2000 Novel TSHR germline mutation (Met463-Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 10:1035-1041.
6. Biebermann H, Schoneberg T, Hess C, Germak J, Gudermann T, Gruters A 2001 The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 86:4429-4433.
7. Lee YS, Poh L, Loke KY 2002 An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism. J Pediatr Endocrinol Metab 15:211-215.
8. Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT, Ellard S 2004 Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol (Oxf) 60:711-718.
9. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Fuhrer D
10. Novel thyrotropin receptor germline mutation (Ile568-Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism. Thyroid 15:1089-1094.
11. Elgadi A, Arvidsson CG, Janson A, Marcus C, Costagliola S, Norgren S 2005 Autosomal-dominant non-autoimmune hyperthyroidism presenting with neuromuscular symptoms. Acta Paediatr 94:1145-1148.
12. Nwosu BU, Gourgiotis L, Gershengorn MC, Neumann S
13. A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism. Thyroid 16:505-512.
14. Ringkananont U, Van Durme J, Montanelli L, Ugrasbul F, Yu YM, Weiss RE, Refetoff S, Grasberger H 2006 Repulsive separation of the cytoplasmic ends of transmembrane helices 3 and 6 is linked to receptor activation in a novel thyrotropin receptor mutant (M626I). Mol Endocrinol 20:893-903.
15. Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G, Persani L 2001 A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 145:249-254.
16. Arturi F, Chiefari E, Tumino S, Russo D, Squatrito S, Chazenbalk G, Persani L, Rapoport B, Filetti S 2002 Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation. J Endocrinol Invest 25:696-701.
17. Schwab KO, Gerlich M, Broecker M, Sohlemann P, Derwahl M, Lohse MJ 1997 Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 131:899-904.
18. Fuhrer D, Wonerow P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238.
19. Nishihara E, Nagayama Y, Amino N, Hishinuma A, Takano T, Yoshida H, Kubota S, Fukata S, Kuma K, Miyauchi A 2007 A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism. Endocr J 54:927-934.
20. Supornsilchai V, Sahakitrungruang T, Wongjitrat N, Wacharasindhu S, Suphapeetiporn K, Shotelersuk V 2009 Expanding clinical spectrum of non-autoimmune hyperthyroidism due to an activating germline mutation, p. M453T, in the thyrotropin receptor gene. Clin Endocrinol (Oxf) 70:623-628.
21. Ferrara AM, Capalbo D, Rossi G, Capuano S, Del Prete G, Esposito V, Montesano G, Zampella E, Fenzi G, Salerno M, Macchia PE 2007 A new case of familial nonautoimmune hyperthyroidism caused by the M463V mutation in the TSH receptor with anticipation of the disease across generations: a possible role of iodine supplementation. Thyroid 17:677-680.
22. Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De Leener A, Vassart G, Costagliola S 2008 A family with a novel TSH receptor activating germline mutation (p. Ala485Val). Eur J Pediatr 167:1231-1237.
23. Pohlenz J, Pfarr N, Kruger S, Hesse V 2006 Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R). Acta Paediatr 95:1685-1687.
24. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T 1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431-1436.
25. Nishihara E, Fukata S, Hishinuma A, Kudo T, Ohye H, Ito M, Kubota S, Amino N, Kuma K, Miyauchi A 2006 Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu 512 Gln) in a Japanese patient. Endocr J 53:735-740.
26. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746.
27. Corvilain B, Van Sande J, Dumont JE, Vassart G 2001 Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55:143-158.
28. 2+ cascades. Mol Endocrinol 9:725-733.
29. Tonacchera M, Agretti P, Rosellini V, Ceccarini G, Perri A, Zampolli M, Longhi R, Larizza D, Pinchera A, Vitti P, Chiovato L 2000 Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid 10:859-863.
30. Farid NR, Kascur V, Balazs C 2000 The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations. Eur J Endocrinol 143:25-30.
31. Farid NR, Szkudlinski MW 2004 Minireview: structural and functional evolution of the thyrotropin receptor. Endocrinology 145:4048-4057.
32. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E 2002 Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 13:336-343.
33. Lueblinghoff J, Mueller S, Sontheimer J, Paschke R 2010 Lack of consistent association of TSH receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism. J Endocrinol Invest 33:228-233.
34. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van Sande J, Noguchi S 2002 Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol 147:287-291.
35. Nishihara E, Amino N, Maekawa K, Yoshida H, Ito M, Kubota S, Fukata S, Miyauchi A 2009 Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan. Endocr J 56:791-798.